News
Advances In Conceptualizing Disease Progression In Alzheimer’s Disease - A hallmark of this year’s ICAD meeting was the wealth of new clinical trials information in Alzheimer’s Disease (AD). Years of basic and preclinical research have paved the road for development of new medications and biologics. Results from many new clinical trials were provided, ranging from promising Phase I and II trials to some disappointing Phase II and III results. Hundreds of new agents for the treatment of dementias are now in or approaching clinical trials.
Alzheimer’s Drug Discovery Foundation Partners With Extreme Athlete Mike Monroe - The Alzheimer’s Drug Discovery Foundation (ADDF), a public charity founded by the Estee Lauder family in 2004, is pleased to announce an exciting partnership with extreme athlete, former Marine, and elite personal trainer Mike Monroe. Mike will be raising money for the ADDF in the 25th anniversary Furnace Creek 508 (The 508) bicycle race on October 4-6, 2008, http://www.the508.com.
Alzheimer’s Society Comment On The Announcement By Carol Thatcher That Baroness Thatcher Has Dementia, UK - Alzheimer’s Society comment on the announcement by Carol Thatcher that Baroness Thatcher has dementia. The sad news that Baroness Thatcher has dementia has highlighted a condition that is desperately under recognised and underfunded in the UK. One in three people over 65 will die with a form of dementia. Dementia is not a natural part of ageing; it is caused by diseases of the brain and robs people of their lives.
Palliative Care Must Be A Priority For Dementia - Alzheimer Scotland welcomes the attention drawn to ‘inconsistencies’ in palliative care for different conditions in the recent Review of palliative care services in Scotland report from Audit Scotland. This report has prompted a pledge from the Scottish Government for a national plan to improve palliative care provision.
Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update - ** NOTE: TRUNCATED STORY ** SAN FRANCISCO , Aug. 11 /PRNewswire-FirstCall/ — Medivation, Inc. today reported on its corporate progress and financial results for the quarter ended June 30, 2008 .
RemeGenix Funded by the Alzheimer’s Drug Discovery Foundation to Commercialize BRI2 Peptides for Use in Treating Alzheimer’s Disease - RemeGenix, Inc. today announced receipt of a $100K investment from the Alzheimer’s Drug Discovery Foundation .
Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of ‘Mr. C’ Causes Major Interest in the Scientific Community - Study findings offer hope for increased life expectancy for people with Down syndrome WASHINGTON , Aug. 18 /PRNewswire-USNewswire/ — In the world of Down syndrome, ‘Mr. C’ is a rarity.
Signs of Alzheimer’s disease may be present decades before diagnosis - WASHINGTON, Aug 11, 2008 — A team of U.S. scientists report on Monday that people who develop Alzheimer’s disease may show signs of the neurodegenerative illness many decades earlier in life, including compromised educational achievement. Scientists from University of South Florida and …
